Health in Estonia 1,140 indicators covering health for Estonia. IndicatorLatest Year10-yr change Rank Number of new leprosy cases with G2D among children 0 2023 — 35th Most sold brand of cigarettes - price in currency reported 4 2020 down 87.5% 165th Most sold brand of cigarettes - taxes as a % of price - total tax 0.9% 2020 up 6.0% 2nd Most sold brand of cigarettes - taxes as a % of price - ad valorem 0.3% 2020 down 9.1% 38th Most sold brand of cigarettes - taxes as a % of price - import duties 0.0% 2020 — 33rd Most sold brand of cigarettes - taxes as a % of price - other taxes 0.0% 2020 — 41st Most sold brand of cigarettes - taxes as a % of price - value added 0.2% 2020 unchanged 19th Most sold brand of cigarettes - taxes as a % of price - specific 0.4% 2020 up 24.2% 40th Most sold brand of cigarettes - price in US$ at official exchange 4.74 2020 up 78.2% 57th Number healthy diet unaffordable 100,000 2024 unchanged 128th Import of environmentally sound technologies 1.19 billion 2020 up 61.8% 69th Percentage of people living with HIV who know their HIV status 98 2025 unchanged 1st Percentage of people living with HIV who know their status receiving 71 2025 up 9.2% 111th Most sold brand of cigarettes - price in PPP$ 7.37 2020 up 108.8% 65th Export of environmentally sound technologies 1.38 billion 2020 up 73.7% 49th Infant mortality 11 2024 down 71.1% 41st Health risks - Regions — Respiratory system diseases mortality crude 56.2 Per 100 000 inhabitants 2024 up 34.4% 27th Health risks - Regions — Circulatory system diseases mortality crude 525.4 Per 100 000 inhabitants 2024 down 16.3% 9th Reported number of human rabies deaths 0 2023 — 62nd Projected life expectancy by age (in completed years), sex and type 88.4 2100 up 1.5% 23rd Assumptions for mortality rates by age, sex and type of projection 0.0017 2100 down 8.1% 30th Projected life expectancy by age, sex and type of projection 87.4 2100 up 2.0% 22nd Assumptions for mortality rates by age, sex and type of projection 0.0003 2100 down 27.8% 24th Projected life expectancy by age (in completed years), sex and type 88.5 2100 up 1.6% 24th Proportion of births delivered in a health facility (Facility births) 99.1% 2022 down 0.2% 36th Life expectancy by age and sex 79.4 2024 up 3.0% 26th Number of non-autochthonous leprosy cases 0 2023 — 47th Crude death rate hmd 11.61 2019 down 3.2% 14th Births and deaths 11.61 2019 down 3.2% 14th Period versus cohort life expectancy 78.8 2019 up 4.8% 29th Annual death rate by age group 1.56 2019 down 56.5% 39th HPV immunization coverage estimates among primary target cohort (9-14) 65.0% 2025 up 25.0% 73rd Life expectancy at birth oecd 77.2 2021 up 0.8% 30th How many health warnings are approved by the law for cigarette 15 2022 down 6.2% 11th Tuberculosis - new and relapse cases 296 2011 down 58.2% 151st Physiotherapists 667 2023 up 77.4% 62nd Health graduates 184 2025 up 38.3% 29th Health personnel 4,911 2024 up 11.2% 27th Coverage of the human papillomavirus vaccine 63 2024 up 31.2% 40th Generalist medical practitioners 1,209 2023 up 14.9% 75th Percentage of principal display area mandated to be covered by health 65 2022 up 85.7% 25th Average of 13 International Health Regulations core capacity scores 70.02 2017 up 7.7% 98th New cases: pulmonary smear-negative 109 2012 down 55.3% 138th Hospital beds by function and type of care 5,664 2024 down 12.0% 30th Percentage of principal display area mandated to be covered by health 65 2022 up 116.7% 26th Percentage of principal display area mandated to be covered by health 65 2022 up 62.5% 30th Average death rate due to natural disasters 0 2018 — 111th Total number of notified TB cases 246 2014 down 58.6% 155th The number of people with susceptibility test result for rifampicin 74 2021 — 113th Specialist medical practitioners 3,563 2023 up 6.6% 61st New cases: pulmonary smear unknown/not done 1 2012 down 75.0% 105th Smear-positive tuberculosis treatment-success rate 59.0% 2011 down 7.8% 165th Share of one year olds who received the rotavirus vaccine 75 2024 up 134.4% 68th How many health warnings are approved by the law for other smoked 15 2022 down 6.2% 12th Insufficiently active 84.07 2016 up 0.8% 64th Percentage of principal display area mandated to be covered by health 65 2022 up 85.7% 22nd The number of people with susceptibility test result for rifampicin 96.1 2021 — 48th Percentage of principal display area mandated to be covered by health 65 2022 up 62.5% 24th Percentage of principal display area mandated to be covered by health 65 2022 up 116.7% 23rd Medical doctors 72.7% 2023 down 3.5% 4th ← Previous Page 17 of 19 Next →